Ekaterine Bachilava
Physician Assistant · New York, NYNPI 1841769288
Payments from drug & device makers
Across 28 payments — averaging $26.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$132
- Novo Nordisk$108
- Incyte Corporation$99
- Aspira Women's Health Inc$69
- CSL Behring$66
- Shield Therapeutics Inc$65
- plus $194 from 6 others
What the payments were for
- Food & beverage$733100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 6 | $132 |
| Novo Nordisk | 4 | $108 |
| Incyte Corporation | 4 | $99 |
| Aspira Women's Health Inc | 1 | $69 |
| CSL Behring | 2 | $66 |
| Shield Therapeutics Inc | 3 | $65 |
| AbbVie | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $46 |
| Boston Scientific | 1 | $37 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Medicomp Inc | 1 | $21 |
| Alk-abello, Inc | 1 | $18 |
How this compares
$733 in reported general payments places this provider in the 70th percentile of 11,358 physician assistant providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carvedilol | 19 | $295 |
| Simvastatin | 13 | $283 |
| Allopurinol | 12 | $271 |
| Levothyroxine Sodium | 18 | $249 |
| Amlodipine Besylate | 15 | $200 |
| Alendronate Sodium | 11 | $139 |
| Fluticasone Propionate | 12 | $118 |
| Metoprolol Succinate | 14 | $110 |
| Losartan Potassium | 14 | $48 |
| Baclofen | 11 | $44 |
| Atorvastatin Calcium | 23 | $23 |
| Meloxicam | 12 | $10 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in New York
- Kristyl Cuenca-SiskoNew York$478K
- Cameron KiserNew York$225K
- Mervat FalahNew York$143K
- Marlene TaylorNew York$109K
- Natalie TafelNew York$77K
- Edwin CalderonNew York$59K
- Jonathan YehNew York$57K
- Emily ElbogenNew York$49K
- Jaclyn ChurchillNew York$48K
- Russell BrandweinNew York$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.